NYSE:RDW
NYSE:RDWAerospace & Defense

Why Redwire (RDW) Is Up 6.9% After Landing a Role in MDA’s SHIELD Mega-Contract

In late January 2026, Redwire Corporation was awarded a position on the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) indefinite-delivery/indefinite-quantity contract, a multi-vendor agreement with a ceiling of US$151.00 billions to rapidly field advanced homeland defense capabilities. The award underscores Redwire’s shift toward integrated space and defense platforms, leveraging its unmanned aerial systems, advanced sensors, and maneuverable...
NYSE:WGO
NYSE:WGOAuto

Is Winnebago Industries (WGO) Pricing Too Rich After Its Recent 30% Monthly Jump

If you are wondering whether Winnebago Industries is a bargain or a value trap at around US$46.65 per share, this breakdown will help you frame that question with actual numbers. The stock is roughly flat over the last year with a 0.2% return. It shows a 13.4% gain over the past 30 days and a 3.8% decline over the last week, alongside longer term 3 year and 5 year returns of 25.8% and 25.4% declines. Recent moves in the share price sit against a backdrop of ongoing interest in RV and outdoor...
NYSE:MSA
NYSE:MSACommercial Services

A Look At MSA Safety (MSA) Valuation After New HVAC-R Refrigerant Management Technologies Debut

MSA Safety (MSA) is back in the spotlight after announcing new refrigerant management and monitoring products ahead of the AHR Expo, an event that has refocused attention on its role in HVAC-R safety and compliance. See our latest analysis for MSA Safety. MSA Safety’s share price has climbed 9.7% year to date and 13.5% over the past 90 days, while the 1 year total shareholder return of 9.2% points to steadier, longer term momentum behind the recent product news and the current US$178.26 share...
NYSE:YUM
NYSE:YUMHospitality

Is It Too Late To Consider Buying Yum Brands (YUM) After Strong Multi Year Share Gains

If you are wondering whether Yum! Brands at around US$155 per share still offers solid value or is getting ahead of itself, you are not alone. The stock has returned 1.3% over the last 7 days, 2.2% over the past month, 3.3% year to date, 21.2% over 1 year, 28.4% over 3 years and 65.7% over 5 years, which naturally raises questions about what is already priced in. Recent news around Yum! Brands has focused on the company's global restaurant portfolio and brand positioning rather than short...
NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

Assessing JetBlue Airways (JBLU) Valuation After Wider Quarterly Loss And Cautious 2026 Outlook

JetBlue Airways (JBLU) stock is in focus after the airline reported a wider fourth quarter loss and issued cautious 2026 guidance, highlighting ongoing cost pressures along with progress in its JetForward operational improvement program. See our latest analysis for JetBlue Airways. At a share price of US$5.05, JetBlue has seen a 20.24% 3 month share price return and a 10.02% year to date share price return. However, the 1 year total shareholder return of 20.09% loss points to momentum...
NasdaqGS:AGNC
NasdaqGS:AGNCMortgage REITs

Will AGNC’s (AGNC) Strong 2025 Earnings and High-Yield Dividend Change Its Income-Focused Narrative?

AGNC Investment Corp. recently reported fourth-quarter 2025 net income of US$954 million, or US$0.83 per basic and diluted share from continuing operations, and full-year net income of US$1.67 billion with earnings per share around US$1.48. Despite missing quarterly earnings and revenue estimates, AGNC paired a high-yield monthly dividend with strong full-year economic returns and a favorable outlook for agency mortgage-backed securities, reinforcing its income-focused profile. We’ll now...
NYSE:SRE
NYSE:SREIntegrated Utilities

Is It Time To Reassess Sempra (SRE) After Recent Share Price Moves?

Investors may be wondering if Sempra is offering fair value at around US$87.10, or if the current price leaves some upside on the table for long term investors. The stock has recently posted a 1.6% gain over the last 7 days, while the 30 day return sits at a 2.2% decline and the year to date move is a 2.9% decline, compared with a longer term return of 8.0% over 1 year, 19.0% over 3 years and 62.0% over 5 years. Recent coverage has focused on Sempra's role as a regulated utilities player and...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Nurix Therapeutics (NRIX) Q4 Loss Highlights Ongoing Profitability Concerns Despite Revenue Progress

Nurix Therapeutics (NRIX) closed out FY 2025 with Q4 revenue of US$13.6 million and a basic EPS loss of US$0.82, while the trailing twelve months show revenue of US$84.0 million and a basic EPS loss of US$3.05. Over recent periods, the company has seen quarterly revenue range from US$7.9 million to US$44.1 million and basic EPS losses move between US$0.52 and US$1.03 per quarter. This sets the backdrop for what remains an early stage, loss making biotech story. For investors, the key question...
NYSE:ARES
NYSE:ARESCapital Markets

Is Ares (ARES) Quietly Redefining Its Strategy With Credit Secondaries And Data Center Expansion?

Ares Management recently reported a series of developments, including a US$1.60 billion direct lending deal for the Suave–Elida Beauty merger, a US$7.10 billion raise for its Credit Secondaries strategy, and continued build‑out of its Ada Infrastructure data center platform. Together with moves to take control of Eagle Football Holdings and active participation in secondary and real assets transactions, these updates underline how broadly Ares is deploying capital across credit, real estate,...
NYSE:DX
NYSE:DXMortgage REITs

Does Dynex’s Leadership Shuffle And Equity Expansion Strengthen Its Mortgage-Backed Securities Strategy For DX?

In late January 2026, Dynex Capital reported fourth-quarter net income of US$185.36 million and full-year 2025 net income of US$319.07 million, while appointing Meakin Bennett as Chief Operating Officer and reallocating Robert Colligan’s responsibilities to focus on the Chief Financial Officer role. Alongside these results, Dynex expanded its at-the-market equity program and highlighted strong total shareholder returns for 2025, underscoring how capital raising and leadership changes are...
NYSE:GE
NYSE:GEAerospace & Defense

Global Minimum Tax And Delta Deal Reshape GE Aerospace Outlook

GE Aerospace, part of General Electric (NYSE:GE), is facing higher tax expenses as Singapore adopts the 15% global minimum corporate tax. The new tax rules are affecting GE Aerospace operations in Singapore, with implications for its overall tax bill and future international tax planning. Separately, GE Aerospace has agreed to supply GEnx engines, spare parts, and long term services to Delta Air Lines for its Boeing 787 10 fleet. The Delta agreement adds a long duration services component in...
NasdaqGS:EXTR
NasdaqGS:EXTRCommunications

Is Extreme Networks (EXTR) Attractive After Recent Share Price Weakness?

Wondering whether Extreme Networks is priced attractively today or if the recent share moves are a warning sign? This article focuses squarely on what you are getting for the current price. The stock last closed at US$14.37, with returns of a 5.4% decline over the past week, a 14.9% decline over the last month, and a 13.1% decline year to date. The 1 year return is a 7.9% decline and the 3 year return is a 23.6% decline, compared with a 5 year return of 61.1%. Recent attention around Extreme...
NasdaqGS:ZD
NasdaqGS:ZDInteractive Media and Services

Ziff Davis Taps AI In Unified RetailMeNot Group To Deepen Engagement

Ziff Davis (NasdaqGS:ZD) has launched the unified RetailMeNot Group, bringing several of its shopping platforms under one banner. The new group introduces AI powered tools designed to improve the online shopping experience for consumers. This move reflects Ziff Davis's focus on digital retail and customer engagement through technology. Ziff Davis, through RetailMeNot Group, is leaning further into digital retail and online deal discovery, an area where consumer expectations for...
NYSE:BIP
NYSE:BIPIntegrated Utilities

Brookfield Infrastructure Partners (NYSE:BIP) Margin Rebound Tests High P/E Bullish Narratives

Brookfield Infrastructure Partners' FY 2025 Earnings Snapshot Brookfield Infrastructure Partners (NYSE:BIP) closed out FY 2025 with fourth quarter revenue of about US$6.3 billion, basic EPS of US$0.40 and net income of US$245 million, putting a spotlight on how its profitability is tracking against expectations. The company has seen revenue move from US$5.4 billion in Q4 2024 to roughly US$6.3 billion in Q4 2025, while basic EPS shifted from US$0.26 to US$0.40 over the same period. This gives...
NYSE:CNMD
NYSE:CNMDMedical Equipment

One Off US$88 Million Loss And Margin Compression Test CONMED (CNMD) Bullish Narratives

CONMED (CNMD) just wrapped up FY 2025 with Q4 revenue of US$373.2 million and basic EPS of US$0.54, alongside trailing twelve month revenue of about US$1.4 billion and EPS of US$1.52. Over the past six quarters in the dataset, revenue has ranged from US$316.7 million to US$373.2 million per quarter, while quarterly EPS has moved between US$0.09 and US$1.59. With trailing net margin sitting at 3.4% versus 10.1% a year earlier, this latest result puts a clear focus on how sustainable the...
NYSE:VRT
NYSE:VRTElectrical

A Look At Vertiv (VRT) Valuation As AI Data Center Growth And Vertiv Next Predict Support Optimism

Vertiv Holdings Co (VRT) has been in focus after launching Vertiv Next Predict, an AI-powered managed service for data centers that uses predictive analytics to spot equipment risks early and streamline maintenance. See our latest analysis for Vertiv Holdings Co. The Vertiv Next Predict launch comes as momentum builds in the shares, with a 7.7% 7 day share price return, an 18.7% 30 day share price return and a 70.5% 1 year total shareholder return pointing to strong recent interest in the AI...
NYSE:HCC
NYSE:HCCMetals and Mining

Warrior Met Coal (HCC) Is Down 6.3% After Blue Creek Ramp-Up Plans Draw Fresh Analyst Optimism

Earlier this week, UBS upgraded Warrior Met Coal to a Buy rating and highlighted the ramp-up of its Blue Creek metallurgical coal project, while Moody’s shifted its outlook on the company to positive. Together, the broker upgrade, credit outlook revision, and expectations for a tight metallurgical coal market have sharpened investor focus on Warrior Met Coal’s growth plans and execution risk at Blue Creek. Next, we will examine how the Blue Creek project’s expected production ramp-up could...
NYSE:RCL
NYSE:RCLHospitality

Royal Caribbean Cruises (RCL) Margin Jump Reinforces Bullish Profitability Narratives

Royal Caribbean Cruises (RCL) has just posted its FY 2025 numbers, with fourth quarter revenue at US$4.3b and basic EPS of US$2.78, capping a trailing twelve month run of US$17.9b in revenue and US$15.75 in EPS. Over recent periods the company has seen quarterly revenue move from US$3.8b and EPS of US$2.05 in Q4 2024 to US$5.1b and EPS of US$5.79 in Q3 2025, before this latest quarter. This sets up the full year against a backdrop of faster earnings growth than revenue and meaningfully higher...
NasdaqGS:UMBF
NasdaqGS:UMBFBanks

UMB Financial Q4 Beat Highlights Integration Progress And Valuation Gap

UMB Financial (NasdaqGS:UMBF) reported strong Q4 results, with earnings that exceeded prior expectations. The company highlighted record quarterly earnings supported by commercial loan activity and disciplined cost management. Management reported successful progress on integrating Heartland Financial, calling it a key milestone for the combined bank. UMB Financial, the parent of UMB Bank, operates across commercial banking, institutional banking, and asset servicing, so Q4 results provide a...
NYSE:AROC
NYSE:AROCEnergy Services

Archrock Dividend Raise Highlights Confidence In Contract Backed Cash Flows

Archrock (NYSE:AROC) has announced an increase in its quarterly dividend. The higher payout was approved by the company's Board of Directors. Archrock, a natural gas compression services provider, sits at the heart of U.S. energy infrastructure, supporting the movement of gas from production fields to end users. For income focused investors, a dividend change at a company tied to midstream energy activity can be a meaningful signal about how management views the business and its capital...
NasdaqGM:KYMR
NasdaqGM:KYMRBiotechs

Assessing Kymera Therapeutics (KYMR) Valuation After Strong 3 Month And 1 Year Share Price Gains

Kymera Therapeutics (KYMR) has drawn attention recently, with the stock up about 19.5% over the past 3 months and about 82.7% over the past year. This performance is prompting investors to reassess its profile. See our latest analysis for Kymera Therapeutics. That recent 3.86% 1 day share price return, together with a 19.5% 90 day share price return and 82.7% 1 year total shareholder return, points to momentum building around Kymera as investors reassess its risk and growth profile following...
NasdaqCM:RGC
NasdaqCM:RGCPharmaceuticals

A Look At Regencell Bioscience Holdings (RGC) Valuation After Market Value Surges Despite Ongoing Challenges

Regencell Bioscience Holdings (RGC) is back in focus after recent coverage highlighted a sharp surge in its market value, despite having no revenue, recurring losses, and an ongoing Justice Department investigation. See our latest analysis for Regencell Bioscience Holdings. The share price has been volatile, with a 1 day share price return of a 13.61% decline and a 7 day share price return of a 9.34% decline. Despite this, it still sits on a 30 day share price return of 21.81% and a 90 day...
NYSE:VFC
NYSE:VFCLuxury

VF Corp (VFC) Q3 Profit Rebound Tests Valuation Concerns In Bullish Narratives

V.F. Corporation (VFC) just posted Q3 2026 results with revenue of US$2.9b and basic EPS of US$0.77, setting a clear reference point for how the year is shaping up. The company has seen quarterly revenue move from US$2.8b in Q2 2026 and US$2.9b in Q3 2025, while EPS shifted from US$0.49 in Q2 2026 and US$0.43 in Q3 2025, giving investors a clean view of how the income statement is trending as margins settle after a volatile period. See our full analysis for V.F. With the latest numbers on the...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Sagebrush Lawsuit Tests Amgen 340B Practices And Investor Risk Views

Sagebrush Health Services has filed a lawsuit accusing Amgen (NasdaqGS:AMGN) of unlawfully terminating discounted drug sales under the federal 340B Drug Pricing Program. The complaint alleges Amgen improperly retracted discounts and reclaimed millions in price concessions that supported clinics serving underserved patients. The dispute centers on access to Amgen therapies for vulnerable populations and the company’s handling of federal discount requirements. Amgen, a large biotechnology...